filovirus
marburgvirus
ebolavirus
nonseg
singlestrand
neg
rna
virus
caus
sever
hemorrhag
fever
mortal
rate
rang
human
develop
efficaci
therapeut
filovirus
hamper
part
limit
knowledg
mechan
virushost
interact
molecular
level
part
lack
suitabl
tool
method
screen
larg
librari
small
molecul
sirna
recent
report
develop
highthroughput
highcont
imag
base
screen
platform
discov
novel
regul
ebov
infect
furthermor
assay
appli
sirna
screen
identifi
valid
host
factor
regul
filoviru
infect
antivir
inhibitor
identifi
primari
screen
potenti
restrict
host
cell
function
critic
cellular
growth
one
simplest
form
inhibit
restrict
cellular
prolifer
vari
degre
eventu
caus
cell
death
grow
evid
number
differ
virus
target
host
cell
cycl
promot
replic
depend
viru
categori
dna
rna
retrovirus
virus
caus
arrest
cell
particular
phase
cell
cycl
replic
rest
cell
other
induc
prolifer
arrest
cell
exampl
neg
strand
rna
virus
like
influenza
prevent
entri
cell
synthesi
phase
cell
cycl
posit
strand
rna
virus
like
infecti
bronchiti
viru
ibv
induc
mitot
arrest
infect
cell
thu
arrest
cell
differ
stage
cell
cycl
virus
provid
favor
condit
replic
molecular
level
anaphas
promot
complex
cyclosom
apcc
multi
compon
ubiquitin
ligas
master
cell
cycl
regul
target
number
virus
replic
although
direct
evid
suggest
filovirus
modul
host
cell
cycl
machineri
replic
gene
express
studi
splenocyt
obtain
mice
infect
ebov
show
signific
regul
gene
associ
cell
cycl
regul
pathway
tradit
cell
cycl
studi
perform
use
flow
cytometri
wherein
dna
dye
propidium
iodid
use
gener
characterist
nuclear
dna
content
profil
addit
method
studi
cell
cycl
includ
measur
express
pattern
prolifer
cell
nuclear
antigen
pcna
marker
progress
cyclin
marker
transit
use
flow
cytometri
immunofluoresc
multiplex
assay
util
combin
dna
stain
brdu
nucleosid
analog
get
incorpor
newli
synthes
dna
also
use
resolv
cell
cycl
phase
use
flow
cytometri
recent
highcont
imag
hci
technolog
appli
studi
effect
therapeut
cell
cycl
singl
cell
level
advantag
use
hci
imag
analysi
sever
hundr
cellular
featur
extract
singl
cell
level
phenotyp
featur
intens
local
fluoresc
label
cellular
compon
dna
protein
well
size
number
textur
shape
subcellular
compart
extract
gener
inform
biolog
process
cell
cycl
statu
cytotox
altern
cell
morpholog
studi
first
optim
highcont
imag
assay
detect
popul
cell
forc
accumul
certain
stage
cell
cycl
follow
serum
starvat
treatment
specif
inhibitor
cell
cycl
investig
potenti
effect
cell
cycl
arrest
ebov
infect
cell
arrest
phase
serum
starvat
phase
use
aphidicolin
nocodazol
respect
infect
ebov
show
reduc
viru
infect
ebov
infect
caus
increas
accumul
cell
phase
although
effect
found
cell
type
depend
implic
find
discuss
measur
dna
content
analyz
differ
phase
cell
cycl
hci
multiplex
assay
set
hela
cell
seed
overnight
well
imag
plate
treat
edu
h
fixat
cell
label
alexa
conjug
small
molecul
detect
edu
base
edu
chemisti
invitrogen
antibodi
phospho
histon
cell
subsequ
stain
hoechst
dye
measur
dna
content
base
nuclear
intens
cell
defin
phase
incorpor
thymidin
analog
edu
phase
immunostain
mitot
marker
phosphohiston
nuclei
label
edu
could
cell
phase
repres
imag
cell
stain
edu
hoechst
anti
antibodi
shown
figur
imag
analysi
normal
integr
nuclear
intens
nini
integr
nuclear
intensitytot
number
nuclei
data
deriv
hoechst
stain
dna
collect
cell
imag
expect
increas
nini
valu
mitot
cell
label
cell
correspond
dna
content
compar
cell
phase
unlabel
cell
figur
cell
label
edu
dna
dna
phase
conveni
simpli
refer
phase
dna
content
result
data
suggest
nini
valu
popul
cell
treat
compound
sirna
differ
significantli
untreat
control
may
reflect
major
chang
cell
cycl
event
specif
popul
confirm
observ
hela
cell
treat
known
inhibitor
block
cell
specif
phase
cell
cycl
imag
analyz
extract
nini
valu
inhibitor
nocodazol
known
inhibit
polymer
microtubul
caus
arrest
phase
dna
content
expect
data
show
dose
depend
increas
rel
nini
valu
correspond
dna
content
compar
untreat
control
cell
figur
compound
aphidicolin
known
inhibit
dna
polymeras
effect
block
cell
dna
replic
subsequ
arrest
cell
boundari
hela
cell
treat
low
concentr
aphidicolin
arrest
phase
measur
increas
nini
valu
high
aphidicolin
concentr
nini
valu
similar
untreat
control
cell
possibl
correspond
phase
figur
final
serum
starvat
hela
cell
arrest
cell
phase
show
enrich
cell
lower
nini
valu
correspond
dna
content
compar
control
cell
incub
medium
contain
serum
figur
base
observ
conclud
measur
nini
valu
base
hoechst
dye
stain
use
broadli
identifi
cell
popul
accumul
certain
stage
cell
cycl
compar
control
cycl
cell
investig
influenc
cell
cycl
arrest
ebola
viru
ebov
infect
hela
cell
serum
starv
h
infect
vari
multipl
infect
moi
ebov
medium
contain
serum
h
viru
remov
cell
incub
h
detect
ebov
fix
cell
stain
anti
gp
antibodi
detect
viral
glycoprotein
gp
acquir
imag
analyz
calcul
percentag
infect
cell
shown
figur
serum
starv
cell
show
much
reduc
percentag
ebov
infect
cell
compar
cell
incub
complet
medium
reduc
ebov
infect
also
observ
serum
starv
human
lung
adenocarcinoma
cell
line
human
nontransform
mammari
epitheli
cell
line
cell
data
shown
result
suggest
ebov
infect
effici
cell
block
phase
cell
cycl
howev
cell
releas
growth
arrest
addit
medium
contain
serum
infect
h
h
releas
increas
ebov
infect
figur
correspond
increas
nini
valu
figur
observ
thu
studi
confirm
ebov
requir
activ
divid
cell
effici
infect
test
effect
cell
cycl
inhibitor
aphidicolin
ebov
infect
hela
cell
treat
differ
concentr
aphidicolin
h
wash
remov
inhibitor
infect
moi
ebov
shown
figur
dose
depend
decreas
percentag
ebov
infect
cell
observ
repres
imag
ebov
infect
hela
cell
dmso
control
aphidicolin
shown
figur
parallel
experi
cell
also
show
dose
depend
reduct
ebov
infect
figur
effici
ebov
infect
studi
cell
releas
aphidicolin
mediat
cell
cycl
arrest
differ
time
point
hela
cell
pretreat
aphidicolin
h
wash
replac
complet
medium
time
point
h
cell
infect
ebov
h
timedepend
increas
ebov
infect
observ
figur
found
correl
normal
cell
cycl
progress
data
shown
treatment
hela
cell
differ
concentr
nocodazol
also
show
dosedepend
reduct
ebov
infect
figur
repres
imag
ebov
infect
cell
pretreat
dmso
control
nocodazol
shown
figur
similar
result
observ
nocodazol
treat
cell
figur
howev
unlik
serum
starvat
aphidicolin
treatment
releas
nocodazol
inhibit
prior
infect
result
timedepend
increas
ebov
infect
figur
one
possibl
reason
cell
yet
reach
appropri
cell
cycl
phase
viru
establish
infect
character
kinet
infect
impact
cell
cycl
requir
address
mechan
action
collect
data
suggest
ebov
infect
favor
activ
prolifer
cell
determin
whether
normal
cell
cycl
progress
could
inhibit
ebov
hela
cell
infect
moi
ebov
h
figur
analyz
flow
cytometri
follow
propidium
iodid
stain
h
differ
cell
cycl
profil
uninfect
ebov
infect
cell
major
cell
accumul
phase
figur
h
increas
cell
death
increas
moi
viru
data
shown
cell
cycl
analysi
ebov
infect
cell
also
display
cell
cycl
defect
data
shown
contrari
ebov
infect
cell
show
approxim
fold
decreas
percentag
cell
phase
figur
increas
accumul
cell
phase
figur
observ
differ
ebov
mediat
cell
cycl
modul
hela
cell
could
due
natur
cell
type
hela
cell
transform
aneuploid
near
diploid
untransform
hela
cell
seed
well
imag
plate
cellswel
next
day
cell
either
left
untreat
wash
incub
serum
free
medium
h
releas
cell
cell
cycl
block
cell
wash
regular
medium
contain
serum
incub
complet
medium
time
point
indic
experi
experi
perform
triplic
repeat
two
independ
time
nocodazol
sigma
aphidicolin
sigma
stock
solut
made
dmso
dilut
requir
concentr
respect
cultur
media
experi
cell
incub
appropri
concentr
inhibitor
h
releas
experi
compound
treat
cell
wash
replac
complet
medium
ebola
infect
assay
hela
cell
seed
imag
plate
either
left
untreat
treat
differ
condit
serum
starvat
cell
cycl
inhibitor
appropri
time
point
cell
wash
infect
ebola
viru
ebov
variant
kitwit
differ
time
point
differ
moi
indic
individu
experi
h
cell
fix
formalin
day
process
immunofluoresc
stain
cell
wash
pb
incub
room
temperatur
rt
block
buffer
bovin
serum
albumin
bsa
pb
detect
viral
gp
express
cell
incub
antigp
antibodi
h
rt
wash
cell
stain
h
rt
goat
antimous
alexa
secondari
antibodi
cell
wash
pb
stain
hc
cellmask
deep
red
cytoplasmicnuclear
stain
invitrogen
mgml
dilut
pb
nuclear
dye
hoechst
invitrogen
mgml
dilut
pb
ebov
infect
experi
perform
triplic
repeat
least
two
independ
time
edu
label
detect
edu
alexa
imag
kit
invitrogen
carlsbad
ca
usa
use
per
manufactur
suggest
protocol
briefli
hela
cell
grown
confluenc
well
imag
plate
incub
edu
h
prior
fixat
formaldehyd
cell
wash
pb
permeabil
min
triton
pb
wash
pb
detect
edu
cell
incub
min
reaction
cocktail
follow
wash
reaction
rins
buffer
mitot
cell
detect
use
phospho
histon
primari
antibodi
cell
signal
technolog
danver
usa
alexa
goat
antirabbit
secondari
antibodi
invitrogen
wash
cell
stain
nuclear
dye
hoechst
dye
label
experi
perform
triplic
repeat
two
independ
time
autom
imag
acquisit
perform
use
opera
confoc
reader
model
excit
high
sensit
qeh
perkinelm
waltham
usa
imag
acquir
exposur
use
air
object
bin
first
exposur
use
laser
excit
viral
cell
bodi
fluorophor
respect
direct
sampl
tripl
dichroic
emiss
light
split
sp
dichroic
mirror
collect
separ
camera
bandpass
filter
second
exposur
use
laser
excit
nuclear
alexa
respect
direct
sampl
tripl
dichroic
imag
analyz
within
opera
environ
use
standard
acapella
script
algorithm
use
identifi
object
nuclei
base
hoechst
dye
cytoplasm
base
deep
red
cytoplasmicnuclear
stain
intens
subcellular
local
viral
infect
determin
alexa
fluoresc
condit
imag
fieldswel
cell
acquir
script
calcul
percent
posit
cell
mean
fluoresc
intens
cytoplasm
membran
nuclear
region
fluoresc
nuclear
size
nuclear
intens
use
hoechst
channel
calcul
normal
integr
nuclear
intens
nini
total
integr
nuclear
intens
base
hoechst
channel
divid
total
number
nuclei
per
well
hela
cell
infect
ebov
h
adher
cell
remov
trypsin
suspend
pb
recov
cell
fix
ice
cold
ethanol
minimum
h
wash
cold
pb
sampl
incub
rnase
qiagen
h
addit
propidium
iodid
solut
sigma
sampl
acquir
beckman
coulter
gallio
stop
gate
total
event
analyz
flowjo
softwar
treestar
studi
report
develop
hci
assay
quantit
differ
phase
cell
cycl
imag
analysi
integr
nuclear
intens
measur
base
nuclear
dye
hoechst
normal
cell
number
data
allow
rapid
evalu
cell
arrest
differ
phase
cell
cycl
ad
advantag
imagebas
cell
cycl
analysi
distinguish
phase
cell
latter
smaller
nuclei
data
shown
contrari
flow
cytometri
analysi
cell
cycl
base
dna
stain
alon
distinguish
cell
phase
dna
content
hci
base
small
molecul
screen
possibl
compound
may
target
multipl
pathway
therebi
block
cell
certain
phase
cell
cycl
futur
studi
focu
extend
current
method
extract
phenotyp
featur
nuclear
size
nuclear
intens
morpholog
textur
analyz
cell
cycl
singl
cell
level
use
imagebas
flow
cytometri
tool
applic
hci
assay
studi
interact
ebov
cell
cycl
reveal
cell
block
specif
phase
cell
cycl
restrict
ebov
infect
cell
block
phase
serum
starvat
phase
follow
nocodazol
treatment
phase
aphidicolin
restrict
ebov
infect
previous
publish
report
show
nocodazol
could
potenti
inhibit
ebov
entri
level
viru
egress
releas
cell
cycl
block
induc
serum
starvat
aphidicolin
result
timedepend
increas
ebov
infect
thu
result
suggest
activ
prolifer
cell
requir
ebov
infect
also
possibl
cellular
pathway
mtor
autophagi
activ
upon
serum
starvat
may
potenti
modul
ebov
infect
understand
cellular
pathway
molecular
mechan
mediat
potent
antivir
effect
serum
starvat
use
known
cell
cycl
inhibitor
crucial
therapeut
discoveri
understand
basic
biolog
ebov
infect
abil
ebov
manipul
cell
cycl
progress
studi
three
differ
cell
type
interestingli
infect
cell
caus
accumul
cell
phase
concomit
decreas
cell
phase
howev
ebov
infect
hela
cell
modul
cell
cycl
progress
collect
data
suggest
ebov
requir
activ
divid
cell
effici
infect
ebov
may
provid
favour
condit
viral
product
induc
phase
cell
cycl
arrest
infect
cell
cell
type
depend
manner
